Nexgel (NXGLW) Depreciation & Amortization (CF) (2018 - 2025)
Nexgel's (NXGLW) quarterly Depreciation & Amortization (CF) came in at $112000.0 in Q4 2025, up 3.7% YoY from $108000.0 in Q4 2024, and down 0.88% on a QoQ basis from $113000.0 in Q3 2025.
Nexgel (NXGLW) Depreciation & Amortization (CF) (2018 - 2025) Analysis & Trends
Nexgel (NXGLW) has 8 years of Depreciation & Amortization (CF) data on file, last reported at $112000.0 in Q4 2025.
- Quarterly Depreciation & Amortization (CF) rose 3.7% year-over-year to $112000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $450000.0 (up 3.21% YoY) and the FY2025 annual result came in at $450000.0, up 3.21% from the prior year.
- Depreciation & Amortization (CF) retreated to $112000.0 in Q4 2025, from $113000.0 in the prior quarter.
- In the past five years, Depreciation & Amortization (CF) ranged from a high of $184000.0 in Q3 2024 to a low of -$93000.0 in Q4 2021.
- A 5-year average of $66850.0 and a median of $49500.0 in 2023 frame the typical range for Depreciation & Amortization (CF).
- Annual changes were most pronounced in 2021 — Depreciation & Amortization (CF) tumbled 365.0% — and 2024, when it jumped 425.71%.
- Tracing NXGLW's Depreciation & Amortization (CF) over 5 years: stood at -$93000.0 in 2021, then jumped by 130.11% to $28000.0 in 2022, then soared by 339.29% to $123000.0 in 2023, then dropped by 12.2% to $108000.0 in 2024, then advanced by 3.7% to $112000.0 in 2025.
- The last three Depreciation & Amortization (CF) figures came in at $112000.0 (Q4 2025), $113000.0 (Q3 2025), and $111000.0 (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation & Amortization (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.13 Bn | 128.91 Bn | 1.96 Bn | 192.30 Mn |
| 2 | Becton Dickinson | 52.76 Bn | 51.90 Bn | 2.32 Bn | 564.00 Mn |
| 3 | Alcon | 35.81 Bn | 34.46 Bn | 1.68 Bn | - |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn | 44.78 Mn |
| 5 | Medline | 29.38 Bn | 26.70 Bn | 2.22 Bn | 256.00 Mn |
| 6 | West Pharmaceutical Services | 25.00 Bn | 24.57 Bn | 329.20 Mn | - |
| 7 | Solventum | 15.46 Bn | 15.06 Bn | 1.29 Bn | 133.00 Mn |
| 8 | Cooper Companies | 14.88 Bn | 14.74 Bn | 735.40 Mn | 95.40 Mn |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn | 239.00 Mn |
| 10 | Nexgel | 194,000.44 | -994,999.56 | 1.11 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 112,000.00 |
| Dec 31, 2025 | 112,000.00 |
| Sep 30, 2025 | 113,000.00 |
| Sep 30, 2025 | 113,000.00 |
| Jun 30, 2025 | 111,000.00 |
| Jun 30, 2025 | 111,000.00 |
| Mar 31, 2025 | 114,000.00 |
| Mar 31, 2025 | 114,000.00 |
| Dec 31, 2024 | 108,000.00 |
| Dec 31, 2024 | 108,000.00 |
| Sep 30, 2024 | 184,000.00 |
| Sep 30, 2024 | 184,000.00 |
| Jun 30, 2024 | 82,000.00 |
| Jun 30, 2024 | 82,000.00 |
| Mar 31, 2024 | 62,000.00 |
| Mar 31, 2024 | 62,000.00 |
| Dec 31, 2023 | 123,000.00 |
| Dec 31, 2023 | 123,000.00 |
| Sep 30, 2023 | 35,000.00 |
| Sep 30, 2023 | 35,000.00 |